BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5158138)

  • 1. Effect of hemodialysis on the inhibition of nervous tissue transketolase and on uremic neuropathy.
    Sterzel RB; Semar M; Lonergan ET; Lange K
    Trans Am Soc Artif Intern Organs; 1971; 17():77-9. PubMed ID: 5158138
    [No Abstract]   [Full Text] [Related]  

  • 2. Transketolase inhibition as a mechanism in uremic neuropathy.
    Lange K; Lonergan ET; Semar M; Sterzel RB
    Trans Assoc Am Physicians; 1971; 84():172-81. PubMed ID: 5164301
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of nervous tissue transketolase to the neuropathy in chronic uremia.
    Sterzel RB; Semar M; Lonergan ET; Treser G; Lange K
    J Clin Invest; 1971 Nov; 50(11):2295-304. PubMed ID: 5096513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte transketolase inhibition, neuropathy and uremia.
    Henderson LW
    N Engl J Med; 1971 Jun; 284(25):1435-6. PubMed ID: 4325317
    [No Abstract]   [Full Text] [Related]  

  • 5. Can hemodialysis remove the factor that suppresses platelet cyclo-oxygenase activity in uremic patients?
    Tanaka H; Umimoto K; Izumi N; Maekawa T; Kishimoto T; Maekawa M
    Trans Am Soc Artif Intern Organs; 1985; 31():552-5. PubMed ID: 3939277
    [No Abstract]   [Full Text] [Related]  

  • 6. Transketolase activity in uremia.
    Lonergan ET; Semar M; Lange K
    Arch Intern Med; 1970 Nov; 126(5):851-4. PubMed ID: 5475709
    [No Abstract]   [Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-uremic neuropathy in hemodialysis patients].
    Kondo H; Takeuchi M; Yatabe K; Mochizuki A; Iwata M
    No To Shinkei; 1997 Aug; 49(8):737-43. PubMed ID: 9282368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on lysozyme (muramidase). II. Serum and urine muramidase patterns in chronic uremia, chronic hemodialysis and renal allotransplantation.
    Daniels JC; Fukushima M; Fish JC; Lindley JD; Remmers AR; Sarles HE; Ritzmann SE
    Tex Rep Biol Med; 1972; 30(1):9-22. PubMed ID: 4556682
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia.
    Lonergan ET; Semar M; Sterzel RB; Treser G; Needle MA; Voyles L; Lange K
    N Engl J Med; 1971 Jun; 284(25):1399-403. PubMed ID: 4325316
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasmatic and erythrocytic angiotensinase activity in subjects with chronic uremia before and after treatment with dialysis].
    Ripa R; Degli Atti B; Cavagna R
    Minerva Med; 1970 Mar; 61(26):1307-13. PubMed ID: 4314603
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surgery in uremic patients on chronic hemodialysis].
    Robecchi A; Ginardi A; Scollo MA; Scaglia M; Cattaneo U; Piemontesi F; Bergoglio D; Fronda GR
    Minerva Chir; 1987 Nov; 42(22):1889-92. PubMed ID: 3431717
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of hemosorption on uremic polyneuropathy].
    Riabov SI; Shostka GD; Lukichev BG; Spiridonov VN; Strelko VV
    Urol Nefrol (Mosk); 1981; (1):59-61. PubMed ID: 6259797
    [No Abstract]   [Full Text] [Related]  

  • 14. [The visual apparatus in chronic uremic patients during periodic hemodialytic treatment. 3. Changes in the caliber of the retinal vessels during hemodialysis].
    Sorice PS; Esposito E; Tretola L; Tufano L; Ambrosio A
    Rass Int Clin Ter; 1971 Aug; 51(15):948-52. PubMed ID: 5096694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Some aspects of gastric secretion in chronic uremic patients in periodic hemodialysis].
    Guarini G; Bruscagli GF; Cordova C; Santucci A; Cerulli N; Bruno S
    Minerva Nefrol; 1970; 17(6):181-3. PubMed ID: 5516051
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolidase and prolinase activities in the erythrocytes of patients with chronic uremia.
    Gejyo F; Kishore BK; Arakawa M
    Nephron; 1983; 35(1):58-61. PubMed ID: 6888626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantified functions of the nervous system in uremic patients on maintenance dialysis.
    Teschan PE; Ginn HE; Walker PJ; Bourne JR; Fristoe M; Ward JW
    Trans Am Soc Artif Intern Organs; 1974; 20A():388-92. PubMed ID: 4450361
    [No Abstract]   [Full Text] [Related]  

  • 19. [The intervals of ventricular systole in uremic patients treated with periodic hemodialysis. Polygraphic study].
    Sodi A; Rizzo M; Durval A; Biagioni-Sodi A; Turini D; Pampanini A
    Mal Cardiovasc; 1968; 9(3):441-70. PubMed ID: 5705928
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications and results of periodic hemodialysis in terminal chronic uremia].
    Bonomini V
    Bull Sci Med (Bologna); 1970; 142(1):91-6. PubMed ID: 5479080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.